Lv11
68 积分 2022-12-07 加入
RNAi-based drug design: considerations and future directions
7小时前
待确认
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
6个月前
已完结
Population Pharmacokinetic Analysis of the RNAi Therapeutic Givosiran in Patients with Acute Hepatic Porphyria
6个月前
已完结
Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases
6个月前
已完结
Metabolically Stable Anomeric Linkages Containing GalNAc–siRNA Conjugates: An Interplay among ASGPR, Glycosidase, and RISC Pathways
6个月前
已完结
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once‐weekly basal insulin, in healthy participants: A randomized trial
7个月前
已完结
Flavonoids as Pyruvate Kinase M2 Inhibitor: An in silico Analysis
11个月前
已完结
Rational Design and Synthesis of Novel Benzimidazole Derivatives as Potential β-Glucosidase Inhibitors
11个月前
已完结
The historical study of an ethics for American pharmacists
11个月前
已关闭
Glucose-sensitive insulin with attenuation of hypoglycaemia
1年前
已完结
皖公网安备34019202002308
